Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A

• Váldodahkkit: Liu L (Dahkki), Lu J (Dahkki), Allan BW (Dahkki), Tang Y (Dahkki), Tetreault J (Dahkki), Chow C (Dahkki), Barmettler B (Dahkki), Nelson J (Dahkki), Bina H (Dahkki), Huang L (Dahkki), Wroblewski VJ (Dahkki), Kikly K (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2016-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Ling Liu,1 Jirong Lu,1 Barrett W Allan,2 Ying Tang,2 Jonathan Tetreault,1 Chi-kin Chow,1 Barbra Barmettler,2 James Nelson,2 Holly Bina,1 Lihua Huang,3 Victor J Wroblewski,4 Kristine Kikly1 1Biotechnology Discovery Research, Indianapolis, IN, 2Applied Molecular Evolution, Lilly Biotechnology...